Quick Answer
NeuroPace Inc reported Total Revenue of $99.99 million for fiscal year 2025.
NeuroPace Inc — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $99.99M +25.1% |
$79.91M +22.1% |
$65.42M +43.7% |
$45.52M +0.7% |
$45.18M +9.8% |
$41.14M |
| Revenue (ASC 606) | $99.99M +25.1% |
$79.91M +22.1% |
$65.42M +43.7% |
$45.52M +0.7% |
$45.18M +9.8% |
$41.14M |
| Net Income | -$21.46M +20.9% |
-$27.14M +17.6% |
-$32.96M +30.0% |
-$47.08M -30.5% |
-$36.08M -48.6% |
-$24.28M |
| Diluted EPS | -$0.66 +29.0% |
-$0.93 +26.8% |
-$1.27 +33.5% |
-$1.91 +12.0% |
-$2.17 +98.2% |
-$117.85 |
| Total Assets | $105.56M +11.5% |
$94.65M -12.1% |
$107.65M -5.7% |
$114.11M -14.6% |
$133.56M +138.7% |
$55.95M |
| Cash and Equivalents | $21.69M +61.5% |
$13.43M -25.6% |
$18.06M +173.4% |
$6.61M -65.6% |
$19.19M -27.3% |
$26.39M |
| Long-Term Debt | $58.88M -1.1% |
$59.52M +4.5% |
$56.95M +7.6% |
$52.91M +6.2% |
$49.85M -1.9% |
$50.82M |
| Stockholders Equity | $19.03M +137.5% |
$8.01M -61.2% |
$20.65M -40.6% |
$34.78M -52.7% |
$73.50M +149.7% |
-$147.83M -14.3% |
| R&D Expense | $27.89M +17.9% |
$23.65M +13.8% |
$20.78M -5.3% |
$21.95M +20.5% |
$18.21M +16.0% |
$15.70M |
| Operating Income | -$16.34M +24.6% |
-$21.67M +20.3% |
-$27.17M +33.4% |
-$40.79M -71.9% |
-$23.74M -81.9% |
-$13.05M |
| Gross Profit | $77.22M +30.7% |
$59.09M +22.8% |
$48.12M +48.1% |
$32.49M -2.8% |
$33.44M +10.4% |
$30.27M |
| Shares Outstanding | 33.57M +11.4% |
30.15M +8.3% |
27.82M +11.1% |
25.05M +2.4% |
24.45M +7685.2% |
314,096 |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $27.35M | +29.9% | +16.3% |
| Revenue (ASC 606) | September 30, 2025 | $27.35M | +29.9% | +16.3% |
| Net Income | September 30, 2025 | -$3.50M | +35.9% | +59.6% |
| Diluted EPS | September 30, 2025 | -$0.11 | +42.1% | +57.7% |
| Total Assets | September 30, 2025 | $107.25M | +11.4% | +1.1% |
| Cash and Equivalents | September 30, 2025 | $20.65M | +33.9% | -9.7% |
| Long-Term Debt | September 30, 2025 | $58.75M | -0.9% | +0.2% |
| Stockholders Equity | September 30, 2025 | $18.52M | +88.5% | -4.7% |
| R&D Expense | September 30, 2025 | $6.58M | +14.3% | -3.9% |
| Operating Income | September 30, 2025 | -$2.60M | +38.7% | +61.9% |
| Gross Profit | September 30, 2025 | $21.17M | +37.3% | +16.7% |
| Shares Outstanding | September 30, 2025 | 33.28M | +11.8% | +0.7% |
- NeuroPace Inc reported Total Revenue of $99.99 million for fiscal year 2025.
- NeuroPace Inc showed an increase of +25.1% in Total Revenue compared to the prior fiscal year.
- NeuroPace Inc reported Revenue (ASC 606) of $99.99 million for fiscal year 2025.
- NeuroPace Inc showed an increase of +25.1% in Revenue (ASC 606) compared to the prior fiscal year.
- NeuroPace Inc reported Net Income of -$21.46 million for fiscal year 2025.
- NeuroPace Inc showed an increase of +20.9% in Net Income compared to the prior fiscal year.
- NeuroPace Inc reported Diluted EPS of $0.66 per share (loss) for fiscal year 2025.
- NeuroPace Inc showed an increase of +29.0% in Diluted EPS compared to the prior fiscal year.
- NeuroPace Inc reported Total Assets of $105.56 million for fiscal year 2025.
- NeuroPace Inc showed an increase of +11.5% in Total Assets compared to the prior fiscal year.
- NeuroPace Inc reported Cash and Equivalents of $21.69 million for fiscal year 2025.
- NeuroPace Inc showed an increase of +61.5% in Cash and Equivalents compared to the prior fiscal year.
- NeuroPace Inc reported Long-Term Debt of $58.88 million for fiscal year 2025.
- NeuroPace Inc showed a decrease of -1.1% in Long-Term Debt compared to the prior fiscal year.
- NeuroPace Inc reported Stockholders Equity of $19.03 million for fiscal year 2025.
- NeuroPace Inc showed an increase of +137.5% in Stockholders Equity compared to the prior fiscal year.
- NeuroPace Inc reported R&D Expense of $27.89 million for fiscal year 2025.
- NeuroPace Inc showed an increase of +17.9% in R&D Expense compared to the prior fiscal year.
- NeuroPace Inc reported Operating Income of -$16.34 million for fiscal year 2025.
- NeuroPace Inc showed an increase of +24.6% in Operating Income compared to the prior fiscal year.
- NeuroPace Inc reported Gross Profit of $77.22 million for fiscal year 2025.
- NeuroPace Inc showed an increase of +30.7% in Gross Profit compared to the prior fiscal year.
- NeuroPace Inc reported Shares Outstanding of 33.57 million shares for fiscal year 2025.
- NeuroPace Inc showed an increase of +11.4% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: